Norway· NO-ID_3855AE3B-F383-459F-A275-66FC74E78B34
Yondelis
A trabectedin product containing trabectedin, registered in Norway by Pharma MAr S.A.. The same ATC class is registered in 17 of our 19 countries.
Checked against FEST (Norway) on
Informational only — not a medical device.
Where it is registered
Trabectedin is registered in 17 of 19 countries.
Countries holding a registration under ATC L01CX01 (trabectedin), each read from that country’s own register.
- This record: Norway, from FEST (Norway)
- 9 of them publish a price we can compare per daily dose
Trabectedin · ATC L01CX01
17 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of trabectedin costs, country by country.
Normalised to the WHO defined daily dose (0.13 mg), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Trabectedin · price per daily dose (0.13 mg)
USD · FX 28 Sept 2026
- CH Switzerland$226.47
The record
At a glance
FEST (Norway)- Active substance
- Trabectedin
- Manufacturer
- Pharma MAr S.A.
- Country
- Norway (NO)
- ATC code
- L01CX01
- ATC class
- Trabectedin
- Defined daily dose
- 0.13 mg, P
- Reimbursed
- Not published by this register
- Source register
- FEST (Norway)
- Last checked
- October 2, 2026
Packs & prices · 3
1 priced- no_merkevare_idID_3855AE3B-F383-459F-A275-66FC74E78B34
- no_varenummer0155980.25NOK 6078.7
- gtin7046260155985
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
502 interactions on record for trabectedin.
Graded by severity as the source publishes them — 72 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Trabectedin · interactions on record
502 records
- 72 severe
- 430 moderate
Most severe, free to view
- LonafarnibA16AX20severe
- ConivaptanC03XA02severe
- MipomersenC10AX11severe
- LomitapideC10AX12severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Trabectedin in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- SpainTRABECTEDINA ACCORD 0,25 MG POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION EFGAccord Healthcare S.L.U.
- BelgiumTrabectedin Accord 0.25 mgAccord Healthcare
- SwedenTrabectedin Accord 0,25 mg Pulver till koncentrat till infusionsvätska, lösningAccord Healthcare S.L.U.
- United KingdomTrabectedin 250microgram powder for concentrate for solution for infusion vialsGenus Pharmaceuticals Ltd
- FinlandTrabectedin AccordAccord Healthcare S.L.U.
- PolandTrabectedin AccordAccord Healthcare S.L.U.
- IrelandTrabectedin Accord 0.25 mg powder for concentrate for solution for infusionAccord Healthcare S.L.U.
- CzechiaTRABECTEDIN ACCORDAccord Healthcare S.L.U., Barcelona
Authorised across Europe · EMA
The same active substance is authorised in 28 EEA countries. Names it is sold under:
- Austria · Trabectedin Ever Pharma, Trabectedin Stada
- Belgium · Trabectedin Eg (Eurogenerics), Trabectedin Ever Pharma
- Bulgaria · Трабектедин Ever Pharma
- Czechia · Trabectedin Ever Pharma
- Germany · Trabectedin Ever Pharma, Trabectedin Ratiopharm
- Denmark · Trabectedin Teva, Trabektedin
- Estonia · Trabectedin Ever Pharma
- Spain · Trabectedina, Trabectedina Ever Pharma
- Finland · Trabectedin, Trabectedin Ever Pharma
- France · Trabectedin, Trabectedin Ever Pharma
- United Kingdom (Northern Ireland) · Trabectedin Accord Healthcare, Trabectedin Genus Pharmaceuticals Ltd.
- Greece · Trabectedin Ever Pharma, Trabectedin Teva
- Croatia · Trabektedin Ever Pharma, Trabektedin Teva
- Hungary · Trabectedin, Trabectedin Ever Pharma
- Ireland · Trabectedin Ever Pharma
- Iceland · Trabectedin Accord, Yondelis
- Italy · Trabectedina Eg Spa, Trabectedina Ever Pharma
- Liechtenstein · Trabectedin Accord, Yondelis
- Lithuania · Trabectedin Ever Pharma
- Luxembourg · Trabectedin Eg (Eurogenerics) Nv, Trabectedine Teva
- Latvia · Trabectedin Ever Pharma
- Netherlands · Trabectedine Ever Pharma, Trabectedine Teva
- Poland · Trabectedin Ever Pharma
- Portugal · Trabectedina Ever Pharma, Trabectedina Teva
- Romania · Trabectedin Ever Pharma, Trabectedin Teva
- Sweden · Trabectedin Ever Pharma, Trabectedin Stada
- Slovenia · Trabektedin Ever Pharma, Trabektedin Teva
- Slovakia · Trabectedin Ever Pharma, Trabectedin Teva
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FEST (Norway). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/8d1c190f-b7ab-45ea-977e-ced1a6157907 GET /v1/drugs/8d1c190f-b7ab-45ea-977e-ced1a6157907?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Pulver til konsentrat til infusjonsvæske, oppløsning",
"source": "fest",
"status": "A",
"atc_name": "Trabektedin",
"merkevare_id": "ID_3855AE3B-F383-459F-A275-66FC74E78B34",
"name_form_strength": "Yondelis pulv til kons til inf væske, oppl 0,25 mg",
"prescription_group": "C"
}See everything about trabectedin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.